Ozurdex (a slow-release dexamethasone implant) in proliferative vitreoretinopathy: study protocol for a randomised controlled trial.
about
Preparation and evaluation of a novel biodegradable long-acting intravitreal implant containing ligustrazine for the treatment of proliferative vitreoretinopathy.Spontaneous relocation of a trapped retrolenticular slow-release dexamethasone implant (Ozurdex) in a silicone oil-filled eye of a pseudophakic patient.Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.Comparison of the effects of intravitreal bevacizumab and dexamethasone in experimental posterior penetrating eye injury.
P2860
Ozurdex (a slow-release dexamethasone implant) in proliferative vitreoretinopathy: study protocol for a randomised controlled trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Ozurdex (a slow-release dexame ...... a randomised controlled trial.
@en
Ozurdex
@nl
type
label
Ozurdex (a slow-release dexame ...... a randomised controlled trial.
@en
Ozurdex
@nl
prefLabel
Ozurdex (a slow-release dexame ...... a randomised controlled trial.
@en
Ozurdex
@nl
P2860
P356
P1433
P1476
Ozurdex (a slow-release dexame ...... a randomised controlled trial.
@en
P2093
David G Charteris
Philip J Banerjee
P2860
P2888
P356
10.1186/1745-6215-14-358
P50
P577
2013-10-28T00:00:00Z
P5875
P6179
1018097998